All articles by Phillip Broadwith
-
OpinionWidening impact of conflict in Iran
Deyond hydrocarbons, helium and sulfur – byproducts of petroleum extraction – have also been critically affected by Iran’s blockade of Gulf exports
-
PodcastAtomic radii & synthetic food dyes
In this episode, we discuss the where the true limits of an atom lie, the US’s plan to eliminate synthetic food dyes, and hear the latest headlines
-
OpinionHydrogen bubble’s squeaky pop
Were cancelled hydrogen production projects overly optimistic or commitments of convenience?
-
OpinionAre food colour clashes worth the worry?
Calling artificial colours ‘petroleum-based poisons’ plays to popular fears, not necessarily evidence
-
OpinionModerna’s vaccine regulatory hokey-cokey
US FDA initially refused to accept flu vaccine for review, but has since reversed that decision
-
OpinionSlimming down competition over weight-loss drugs
Legal battle between Novo Nordisk and US compounding pharmacy Hims & Hers has fizzled after regulator intervention
-
OpinionProbing PFAS policies in the UK and EU
The UK has set out its approach to regulating fluorochemicals, and the EU has projected the savings from a proposed ban
-
PodcastBench-stable butyllithium & secrets of Pompeii’s limescale
In this episode, we discuss the latest formulations designed to make a set of fiery reagents safer, explore what limescale can tell us about ancient civilizations and hear the latest headlines.
-
OpinionCarbon border taxes may do more harm than good
Industry argues UK proposals are flawed and will not promote decarbonisation
-
OpinionTrump’s attack on science is shaking industry’s foundations
By dismantling scientific enterprise, the US risks ‘taking a hammer to our miracle machine’
-
OpinionPlastic recycling’s perfect storm
Pending policies that demand more recycling cannot offset problems of high costs and competition from cheap virgin polymers
-
OpinionReprieve for Grangemouth ethylene
UK government agrees £150 million deal to support the country’s last ethylene production plant
-
OpinionA unifying force for African medicines
The new African Medicines Agency is hugely important but faces significant challenges
-
OpinionChanging the rules of global chemicals trade
Chemical dumping claims reflect US and China’s focus on national interests ahead of global markets
-
OpinionInhaler propellant switch is worth the effort
Memories of a year spent testing new inhaler valve designs
-
BusinessUS judge to approve Purdue’s opioid bankruptcy deal
Settlement allows for future lawsuits against Sackler family owners
-
OpinionA robotic helping hand
Mechanical labmates are making huge progress, but there are still big challenges to overcome
-
BusinessPfizer wins bidding war for Metsera and its weight-loss drugs
US firm matched Novo Nordisk’s rival bid and had backing of competition regulator
-
BusinessPfizer and Novo Nordisk’s battle over Metsera
Lawsuits fly in bidding war over developer of next generation weight loss drugs
-
OpinionSpin-out support is stretched thin
University entrepreneurs need more consistent help to bridge the gap betweeen ideas and businesses